Sheryle Bolton Purchases 10,000 Shares of Tivic Health Systems (NASDAQ:TIVC) Stock

Posted by Alphonse Anthony on Apr 22nd, 2026

Tivic Health Systems, Inc. (NASDAQ:TIVC – Get Free Report) Director Sheryle Bolton purchased 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 15th. The stock was bought at an average cost of $1.04 per share, for a total transaction of $10,400.00. Following the completion of the purchase, the director directly owned 10,000 shares in the company, valued at $10,400. This represents a ? increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Tivic Health Systems Stock Up 2.7%

TIVC stock opened at $1.16 on Wednesday. The company has a market cap of $3.34 million, a price-to-earnings ratio of -0.17 and a beta of 1.84. The company has a current ratio of 20.13, a quick ratio of 20.13 and a debt-to-equity ratio of 0.38. Tivic Health Systems, Inc. has a 12 month low of $0.72 and a 12 month high of $13.23. The firm has a 50-day moving average of $0.92 and a two-hundred day moving average of $1.56.

Tivic Health Systems (NASDAQ:TIVC – Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported ($1.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($408.00) by $406.97.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tivic Health Systems in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Get Our Latest Stock Report on Tivic Health Systems

About Tivic Health Systems

(Get Free Report)

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.